2-[5-[7-[6-benzyl-4-(hydroxymethyl)-5-methylpyridazin-3-yl]-4,7-diazaspiro[2.5]octan-4-yl]pyrazin-2-yl]propan-2-ol
C26H32N6O2 — CID 143926370
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-[7-[6-benzyl-4-(hydroxymethyl)-5-methylpyridazin-3-yl]-4,7-diazaspiro[2.5]octan-4-yl]pyrazin-2-yl]propan-2-ol
2-[5-[7-[6-benzyl-4-(hydroxymethyl)-5-methylpyridazin-3-yl]-4,7-diazaspiro[2.5]octan-4-yl]pyrazin-2-yl]propan-2-ol (PubChem CID 143926370) has the molecular formula C26H32N6O2 and a molecular weight of 460.58 g/mol. Its IUPAC name is 2-[5-[7-[6-benzyl-4-(hydroxymethyl)-5-methylpyridazin-3-yl]-4,7-diazaspiro[2.5]octan-4-yl]pyrazin-2-yl]propan-2-ol.
Molecular Properties
| Compound Name | 2-[5-[7-[6-benzyl-4-(hydroxymethyl)-5-methylpyridazin-3-yl]-4,7-diazaspiro[2.5]octan-4-yl]pyrazin-2-yl]propan-2-ol |
|---|---|
| PubChem CID | 143926370 |
| Molecular Formula | C26H32N6O2 |
| Molecular Weight | 460.58 g/mol |
| Exact Mass | 460.26 |
| IUPAC Name | 2-[5-[7-[6-benzyl-4-(hydroxymethyl)-5-methylpyridazin-3-yl]-4,7-diazaspiro[2.5]octan-4-yl]pyrazin-2-yl]propan-2-ol |
| SMILES | Cc1c(Cc2ccccc2)nnc(N2CCN(c3cnc(C(C)(C)O)cn3)C3(CC3)C2)c1CO |
| InChI | InChI=1S/C26H32N6O2/c1-18-20(16-33)24(30-29-21(18)13-19-7-5-4-6-8-19)31-11-12-32(26(17-31)9-10-26)23-15-27-22(14-28-23)25(2,3)34/h4-8,14-15,33-34H,9-13,16-17H2,1-3H3 |
| InChIKey | MGYBKKWRJUUENP-UHFFFAOYSA-N |
| XLogP | 2.74 |
| TPSA | 98.50 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 460.58 |
| LogP ≤ 5 | 2.74 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143926370 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.